context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
Dividends per share paid to shareholders were $ 7.00 , $ 7.00 and $ 7.00 during 2024, 2023 and 2022, respectively. | text | 7.00 | perShareItemType | text: <entity> 7.00 </entity> <entity type> perShareItemType </entity type> <context> Dividends per share paid to shareholders were $ 7.00 , $ 7.00 and $ 7.00 during 2024, 2023 and 2022, respectively. </context> | us-gaap:CommonStockDividendsPerShareCashPaid |
On April 19, 2021, our Board of Directors authorized a share repurchase program of up to $ 2 billion, which has no expiration date. On February 14, 2022, the Board of Directors authorized an additional $ 2 billion in share repurchases under the Company's ongoing share repurchase program. During the twelve months ended December 31, 2024, we repurchased 456,000 shares under the share repurchase program at an aggregate price of approximately $ 50 million. At December 31, 2024, there were approximately $ 2.5 billion in remaining funds authorized under these programs. | text | 456000 | sharesItemType | text: <entity> 456000 </entity> <entity type> sharesItemType </entity type> <context> On April 19, 2021, our Board of Directors authorized a share repurchase program of up to $ 2 billion, which has no expiration date. On February 14, 2022, the Board of Directors authorized an additional $ 2 billion in share repurchases under the Company's ongoing share repurchase program. During the twelve months ended December 31, 2024, we repurchased 456,000 shares under the share repurchase program at an aggregate price of approximately $ 50 million. At December 31, 2024, there were approximately $ 2.5 billion in remaining funds authorized under these programs. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
On April 19, 2021, our Board of Directors authorized a share repurchase program of up to $ 2 billion, which has no expiration date. On February 14, 2022, the Board of Directors authorized an additional $ 2 billion in share repurchases under the Company's ongoing share repurchase program. During the twelve months ended December 31, 2024, we repurchased 456,000 shares under the share repurchase program at an aggregate price of approximately $ 50 million. At December 31, 2024, there were approximately $ 2.5 billion in remaining funds authorized under these programs. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> On April 19, 2021, our Board of Directors authorized a share repurchase program of up to $ 2 billion, which has no expiration date. On February 14, 2022, the Board of Directors authorized an additional $ 2 billion in share repurchases under the Company's ongoing share repurchase program. During the twelve months ended December 31, 2024, we repurchased 456,000 shares under the share repurchase program at an aggregate price of approximately $ 50 million. At December 31, 2024, there were approximately $ 2.5 billion in remaining funds authorized under these programs. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
On April 19, 2021, our Board of Directors authorized a share repurchase program of up to $ 2 billion, which has no expiration date. On February 14, 2022, the Board of Directors authorized an additional $ 2 billion in share repurchases under the Company's ongoing share repurchase program. During the twelve months ended December 31, 2024, we repurchased 456,000 shares under the share repurchase program at an aggregate price of approximately $ 50 million. At December 31, 2024, there were approximately $ 2.5 billion in remaining funds authorized under these programs. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> On April 19, 2021, our Board of Directors authorized a share repurchase program of up to $ 2 billion, which has no expiration date. On February 14, 2022, the Board of Directors authorized an additional $ 2 billion in share repurchases under the Company's ongoing share repurchase program. During the twelve months ended December 31, 2024, we repurchased 456,000 shares under the share repurchase program at an aggregate price of approximately $ 50 million. At December 31, 2024, there were approximately $ 2.5 billion in remaining funds authorized under these programs. </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
We sponsor several share-based employee incentive plans. Share-based compensation expense for grants awarded under these plans was $ 28 million | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> We sponsor several share-based employee incentive plans. Share-based compensation expense for grants awarded under these plans was $ 28 million </context> | us-gaap:AllocatedShareBasedCompensationExpense |
$ 33 million and $ 58 million in 2024, 2023, and 2022, respectively. Related income tax benefits recognized in earnings were | text | 33 | monetaryItemType | text: <entity> 33 </entity> <entity type> monetaryItemType </entity type> <context> $ 33 million and $ 58 million in 2024, 2023, and 2022, respectively. Related income tax benefits recognized in earnings were </context> | us-gaap:AllocatedShareBasedCompensationExpense |
$ 33 million and $ 58 million in 2024, 2023, and 2022, respectively. Related income tax benefits recognized in earnings were | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> $ 33 million and $ 58 million in 2024, 2023, and 2022, respectively. Related income tax benefits recognized in earnings were </context> | us-gaap:AllocatedShareBasedCompensationExpense |
$ 4 million, $ 7 million and $ 10 million in 2024, 2023, and 2022, respectively. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> $ 4 million, $ 7 million and $ 10 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
$ 4 million, $ 7 million and $ 10 million in 2024, 2023, and 2022, respectively. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> $ 4 million, $ 7 million and $ 10 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
$ 4 million, $ 7 million and $ 10 million in 2024, 2023, and 2022, respectively. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> $ 4 million, $ 7 million and $ 10 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
At December 31, 2024, unrecognized compensation cost related to non-vested stock option and stock unit awards totaled $ 62 million. The cost of these non-vested awards is expected to be recognized over a weighted-average remaining vesting period of 26 | text | 62 | monetaryItemType | text: <entity> 62 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, unrecognized compensation cost related to non-vested stock option and stock unit awards totaled $ 62 million. The cost of these non-vested awards is expected to be recognized over a weighted-average remaining vesting period of 26 </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
On April 18, 2023, our stockholders approved the 2023 Omnibus Stock and Incentive Plan ("2023 OSIP"). This plan was adopted by our Board of Directors on February 20, 2023 and provides for the issuance of stock options, performance stock units, and restricted stock units, among other award types. No new awards may be granted under the 2023 OSIP after the tenth anniversary of the date that the stockholders approved the plan. However, the term and exercise of awards granted before then may extend beyond that date. At December 31, 2024, approximately 2.9 million shares remain available for issuance under the 2018 and 2023 OSIP. | text | 2.9 | sharesItemType | text: <entity> 2.9 </entity> <entity type> sharesItemType </entity type> <context> On April 18, 2023, our stockholders approved the 2023 Omnibus Stock and Incentive Plan ("2023 OSIP"). This plan was adopted by our Board of Directors on February 20, 2023 and provides for the issuance of stock options, performance stock units, and restricted stock units, among other award types. No new awards may be granted under the 2023 OSIP after the tenth anniversary of the date that the stockholders approved the plan. However, the term and exercise of awards granted before then may extend beyond that date. At December 31, 2024, approximately 2.9 million shares remain available for issuance under the 2018 and 2023 OSIP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
$ 37.55 and $ 53.16 , respectively, using the following assumptions: | text | 37.55 | perShareItemType | text: <entity> 37.55 </entity> <entity type> perShareItemType </entity type> <context> $ 37.55 and $ 53.16 , respectively, using the following assumptions: </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
$ 37.55 and $ 53.16 , respectively, using the following assumptions: | text | 53.16 | perShareItemType | text: <entity> 53.16 </entity> <entity type> perShareItemType </entity type> <context> $ 37.55 and $ 53.16 , respectively, using the following assumptions: </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
$ 48 million, $ 76 million and $ 67 million, respectively. | text | 48 | monetaryItemType | text: <entity> 48 </entity> <entity type> monetaryItemType </entity type> <context> $ 48 million, $ 76 million and $ 67 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
$ 48 million, $ 76 million and $ 67 million, respectively. | text | 76 | monetaryItemType | text: <entity> 76 </entity> <entity type> monetaryItemType </entity type> <context> $ 48 million, $ 76 million and $ 67 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
$ 48 million, $ 76 million and $ 67 million, respectively. | text | 67 | monetaryItemType | text: <entity> 67 </entity> <entity type> monetaryItemType </entity type> <context> $ 48 million, $ 76 million and $ 67 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
In March 2024, the Company committed to workforce reduction plans in the United States and globally, in an effort to reduce complexity and simplify our organizational model after the European major domestic appliance transaction. The workforce reduction plans included involuntary severance actions as of the end of the first quarter of 2024. Total costs for these actions were $ 21 million, of which we incurred $ 14 million in employee termination costs and $ 7 million other associated costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company committed to workforce reduction plans in the United States and globally, in an effort to reduce complexity and simplify our organizational model after the European major domestic appliance transaction. The workforce reduction plans included involuntary severance actions as of the end of the first quarter of 2024. Total costs for these actions were $ 21 million, of which we incurred $ 14 million in employee termination costs and $ 7 million other associated costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. </context> | us-gaap:RestructuringAndRelatedCostExpectedCost1 |
In March 2024, the Company committed to workforce reduction plans in the United States and globally, in an effort to reduce complexity and simplify our organizational model after the European major domestic appliance transaction. The workforce reduction plans included involuntary severance actions as of the end of the first quarter of 2024. Total costs for these actions were $ 21 million, of which we incurred $ 14 million in employee termination costs and $ 7 million other associated costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company committed to workforce reduction plans in the United States and globally, in an effort to reduce complexity and simplify our organizational model after the European major domestic appliance transaction. The workforce reduction plans included involuntary severance actions as of the end of the first quarter of 2024. Total costs for these actions were $ 21 million, of which we incurred $ 14 million in employee termination costs and $ 7 million other associated costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. </context> | us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 |
In March 2024, the Company committed to workforce reduction plans in the United States and globally, in an effort to reduce complexity and simplify our organizational model after the European major domestic appliance transaction. The workforce reduction plans included involuntary severance actions as of the end of the first quarter of 2024. Total costs for these actions were $ 21 million, of which we incurred $ 14 million in employee termination costs and $ 7 million other associated costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company committed to workforce reduction plans in the United States and globally, in an effort to reduce complexity and simplify our organizational model after the European major domestic appliance transaction. The workforce reduction plans included involuntary severance actions as of the end of the first quarter of 2024. Total costs for these actions were $ 21 million, of which we incurred $ 14 million in employee termination costs and $ 7 million other associated costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. </context> | us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 |
During the second quarter of 2024, the Company evaluated additional restructuring actions as part of the Company's organizational simplification efforts. Total costs for these actions were $ 58 million, which were primarily employee termination costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> During the second quarter of 2024, the Company evaluated additional restructuring actions as part of the Company's organizational simplification efforts. Total costs for these actions were $ 58 million, which were primarily employee termination costs. The majority of these costs resulted in cash settlements in 2024; the remainder will be paid in 2025. </context> | us-gaap:RestructuringCharges |
Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. </context> | us-gaap:IncomeTaxExpenseBenefit |
Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. | text | 77 | monetaryItemType | text: <entity> 77 </entity> <entity type> monetaryItemType </entity type> <context> Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. </context> | us-gaap:IncomeTaxExpenseBenefit |
Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. | text | 265 | monetaryItemType | text: <entity> 265 </entity> <entity type> monetaryItemType </entity type> <context> Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. </context> | us-gaap:IncomeTaxExpenseBenefit |
Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. | text | 721 | monetaryItemType | text: <entity> 721 </entity> <entity type> monetaryItemType </entity type> <context> Income tax expense was $ 10 million, $ 77 million, and $ 265 million in 2024, 2023 and 2022, respectively. The decrease in tax expense in 2024 compared to 2023 includes lower earnings and legal entity restructuring tax benefits related to simplifying our legal entity structure in 2024 to reduce administrative costs associated with the prior structure. The completion of the restructuring in 2024 created a tax deductible loss which was recognized in 2024 and resulted in a $ 721 million net tax benefit partially offset by increases in valuation allowances and the divestiture tax impact. </context> | us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges |
The change in tax expense in 2023 compared to 2022 includes legal entity restructuring tax benefits, related to simplifying the legal entity structure to reduce administrative costs associated with the prior structure. The completion of the restructuring created a tax-deductible loss which was recognized in the fourth quarter of 2023, and resulted in a $ 170 million net tax benefit, partially offset by increases in valuation allowances. | text | 170 | monetaryItemType | text: <entity> 170 </entity> <entity type> monetaryItemType </entity type> <context> The change in tax expense in 2023 compared to 2022 includes legal entity restructuring tax benefits, related to simplifying the legal entity structure to reduce administrative costs associated with the prior structure. The completion of the restructuring created a tax-deductible loss which was recognized in the fourth quarter of 2023, and resulted in a $ 170 million net tax benefit, partially offset by increases in valuation allowances. </context> | us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges |
We have historically reinvested all unremitted earnings of the majority of our foreign subsidiaries and affiliates, and therefore have not recognized any U.S. deferred tax liability on those earnings. The Company had cash and cash equivalents of approximately $ 1.3 billion at December 31, 2024, of which approximately $ 1.1 billion was held by subsidiaries in foreign countries. Certain funds outside of the United States could be repatriated to fund our U.S. operations. If these funds were | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> We have historically reinvested all unremitted earnings of the majority of our foreign subsidiaries and affiliates, and therefore have not recognized any U.S. deferred tax liability on those earnings. The Company had cash and cash equivalents of approximately $ 1.3 billion at December 31, 2024, of which approximately $ 1.1 billion was held by subsidiaries in foreign countries. Certain funds outside of the United States could be repatriated to fund our U.S. operations. If these funds were </context> | us-gaap:CashAndCashEquivalentsAtCarryingValue |
We have historically reinvested all unremitted earnings of the majority of our foreign subsidiaries and affiliates, and therefore have not recognized any U.S. deferred tax liability on those earnings. The Company had cash and cash equivalents of approximately $ 1.3 billion at December 31, 2024, of which approximately $ 1.1 billion was held by subsidiaries in foreign countries. Certain funds outside of the United States could be repatriated to fund our U.S. operations. If these funds were | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> We have historically reinvested all unremitted earnings of the majority of our foreign subsidiaries and affiliates, and therefore have not recognized any U.S. deferred tax liability on those earnings. The Company had cash and cash equivalents of approximately $ 1.3 billion at December 31, 2024, of which approximately $ 1.1 billion was held by subsidiaries in foreign countries. Certain funds outside of the United States could be repatriated to fund our U.S. operations. If these funds were </context> | us-gaap:CashAndCashEquivalentsAtCarryingValue |
At December 31, 2024, we had net operating loss carryforwards of $ 3.8 billion, $ 1.2 billion of which were U.S. state net operating loss carryforwards, compared to $ 5.4 billion and $ 1.2 billion at December 31, 2023, respectively. The | text | 3.8 | monetaryItemType | text: <entity> 3.8 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, we had net operating loss carryforwards of $ 3.8 billion, $ 1.2 billion of which were U.S. state net operating loss carryforwards, compared to $ 5.4 billion and $ 1.2 billion at December 31, 2023, respectively. The </context> | us-gaap:OperatingLossCarryforwards |
At December 31, 2024, we had net operating loss carryforwards of $ 3.8 billion, $ 1.2 billion of which were U.S. state net operating loss carryforwards, compared to $ 5.4 billion and $ 1.2 billion at December 31, 2023, respectively. The | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, we had net operating loss carryforwards of $ 3.8 billion, $ 1.2 billion of which were U.S. state net operating loss carryforwards, compared to $ 5.4 billion and $ 1.2 billion at December 31, 2023, respectively. The </context> | us-gaap:OperatingLossCarryforwards |
At December 31, 2024, we had net operating loss carryforwards of $ 3.8 billion, $ 1.2 billion of which were U.S. state net operating loss carryforwards, compared to $ 5.4 billion and $ 1.2 billion at December 31, 2023, respectively. The | text | 5.4 | monetaryItemType | text: <entity> 5.4 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, we had net operating loss carryforwards of $ 3.8 billion, $ 1.2 billion of which were U.S. state net operating loss carryforwards, compared to $ 5.4 billion and $ 1.2 billion at December 31, 2023, respectively. The </context> | us-gaap:OperatingLossCarryforwards |
decrease in net operating loss carryforwards was primarily driven by the legal entity restructuring actions in 2024. Of the total net operating loss carryforwards at December 31, 2024, $ 1.1 billion do not expire, with substantially all of the remaining carryforwards expiring in various years through 2043. At December 31, 2024, we had $ 363 million of United States general business credit carryforwards available to offset future payments of federal income taxes, expiring between 2031 and 2043. | text | 363 | monetaryItemType | text: <entity> 363 </entity> <entity type> monetaryItemType </entity type> <context> decrease in net operating loss carryforwards was primarily driven by the legal entity restructuring actions in 2024. Of the total net operating loss carryforwards at December 31, 2024, $ 1.1 billion do not expire, with substantially all of the remaining carryforwards expiring in various years through 2043. At December 31, 2024, we had $ 363 million of United States general business credit carryforwards available to offset future payments of federal income taxes, expiring between 2031 and 2043. </context> | us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness |
We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. | text | 885 | monetaryItemType | text: <entity> 885 </entity> <entity type> monetaryItemType </entity type> <context> We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. | text | 601 | monetaryItemType | text: <entity> 601 </entity> <entity type> monetaryItemType </entity type> <context> We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. | text | 284 | monetaryItemType | text: <entity> 284 </entity> <entity type> monetaryItemType </entity type> <context> We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. | text | 490 | monetaryItemType | text: <entity> 490 </entity> <entity type> monetaryItemType </entity type> <context> We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. | text | 393 | monetaryItemType | text: <entity> 393 </entity> <entity type> monetaryItemType </entity type> <context> We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. | text | 97 | monetaryItemType | text: <entity> 97 </entity> <entity type> monetaryItemType </entity type> <context> We routinely review the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies and projected future taxable income. We have recorded a valuation allowance to reflect the net estimated amount of certain deferred tax assets associated with net operating loss and other deferred tax assets we believe will be realized. Our recorded valuation allowance of $ 885 million at December 31, 2024 consists of $ 601 million of net operating loss carryforward deferred tax assets and $ 284 million of other deferred tax assets. Our recorded valuation allowance was $ 490 million at December 31, 2023 and consisted of $ 393 million of net operating loss carryforward deferred tax assets and $ 97 million of other deferred tax assets. The increase in our valuation allowance was primarily driven by the European major domestic appliance business transaction. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
Net operating loss carryforwards in 2023 of $ 2.1 billion related to the European major domestic appliance business as of December 31, 2023. Net deferred tax assets of $ 512 million, including $ 106 million of valuation allowances, associated with the disposal group were transferred to assets held for sale in the fourth quarter of 2023. For additional information, see Notes 10 and 16 to the 2023 Consolidated Financial Statements. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> Net operating loss carryforwards in 2023 of $ 2.1 billion related to the European major domestic appliance business as of December 31, 2023. Net deferred tax assets of $ 512 million, including $ 106 million of valuation allowances, associated with the disposal group were transferred to assets held for sale in the fourth quarter of 2023. For additional information, see Notes 10 and 16 to the 2023 Consolidated Financial Statements. </context> | us-gaap:OperatingLossCarryforwards |
Net operating loss carryforwards in 2023 of $ 2.1 billion related to the European major domestic appliance business as of December 31, 2023. Net deferred tax assets of $ 512 million, including $ 106 million of valuation allowances, associated with the disposal group were transferred to assets held for sale in the fourth quarter of 2023. For additional information, see Notes 10 and 16 to the 2023 Consolidated Financial Statements. | text | 512 | monetaryItemType | text: <entity> 512 </entity> <entity type> monetaryItemType </entity type> <context> Net operating loss carryforwards in 2023 of $ 2.1 billion related to the European major domestic appliance business as of December 31, 2023. Net deferred tax assets of $ 512 million, including $ 106 million of valuation allowances, associated with the disposal group were transferred to assets held for sale in the fourth quarter of 2023. For additional information, see Notes 10 and 16 to the 2023 Consolidated Financial Statements. </context> | us-gaap:DeferredTaxAssetsLiabilitiesNet |
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was enacted into law. Among other changes to the Internal Revenue Code of 1986, as amended (the “Code”), the IRA imposes a 15% corporate alternative minimum tax on certain corporations (the “CAMT”). To the extent a corporation is subject to the CAMT in a prior taxable year and in a later taxable year is subject to the regular corporate tax, such corporation may apply the prior amounts paid under the CAMT against its regular tax liability to the extent such credits do not reduce the regular tax liability below the CAMT applicable in such taxable year. We have no CAMT liability nor related deferred tax asset carryforward as of December 31, 2024. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was enacted into law. Among other changes to the Internal Revenue Code of 1986, as amended (the “Code”), the IRA imposes a 15% corporate alternative minimum tax on certain corporations (the “CAMT”). To the extent a corporation is subject to the CAMT in a prior taxable year and in a later taxable year is subject to the regular corporate tax, such corporation may apply the prior amounts paid under the CAMT against its regular tax liability to the extent such credits do not reduce the regular tax liability below the CAMT applicable in such taxable year. We have no CAMT liability nor related deferred tax asset carryforward as of December 31, 2024. </context> | us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax |
Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. | text | 53 | monetaryItemType | text: <entity> 53 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. | text | 78 | monetaryItemType | text: <entity> 78 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. | text | 90 | monetaryItemType | text: <entity> 90 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties associated with unrecognized tax benefits resulted in a net expense of $ 14 million, net benefit of $ 12 million and net expense of $ 24 million in December 31, 2024, 2023 and 2022, respectively. We have accrued a total of $ 53 million, $ 78 million and $ 90 million at December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
It is reasonably possible that certain unrecognized tax benefits of $ 134 million could be settled with various related jurisdictions during the next 12 months. | text | 134 | monetaryItemType | text: <entity> 134 </entity> <entity type> monetaryItemType </entity type> <context> It is reasonably possible that certain unrecognized tax benefits of $ 134 million could be settled with various related jurisdictions during the next 12 months. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
Sales to Lowe's, a North American retailer, represented approximately 13 %, 13 %, and 14 % of our consolidated net sales in 2024, 2023 and 2022, respectively. Lowe's represented approximately 38 % and 38 % of our consolidated accounts receivable as of December 31, 2024 and 2023, respectively. | text | 13 | percentItemType | text: <entity> 13 </entity> <entity type> percentItemType </entity type> <context> Sales to Lowe's, a North American retailer, represented approximately 13 %, 13 %, and 14 % of our consolidated net sales in 2024, 2023 and 2022, respectively. Lowe's represented approximately 38 % and 38 % of our consolidated accounts receivable as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
Sales to Lowe's, a North American retailer, represented approximately 13 %, 13 %, and 14 % of our consolidated net sales in 2024, 2023 and 2022, respectively. Lowe's represented approximately 38 % and 38 % of our consolidated accounts receivable as of December 31, 2024 and 2023, respectively. | text | 14 | percentItemType | text: <entity> 14 </entity> <entity type> percentItemType </entity type> <context> Sales to Lowe's, a North American retailer, represented approximately 13 %, 13 %, and 14 % of our consolidated net sales in 2024, 2023 and 2022, respectively. Lowe's represented approximately 38 % and 38 % of our consolidated accounts receivable as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
Sales to Lowe's, a North American retailer, represented approximately 13 %, 13 %, and 14 % of our consolidated net sales in 2024, 2023 and 2022, respectively. Lowe's represented approximately 38 % and 38 % of our consolidated accounts receivable as of December 31, 2024 and 2023, respectively. | text | 38 | percentItemType | text: <entity> 38 </entity> <entity type> percentItemType </entity type> <context> Sales to Lowe's, a North American retailer, represented approximately 13 %, 13 %, and 14 % of our consolidated net sales in 2024, 2023 and 2022, respectively. Lowe's represented approximately 38 % and 38 % of our consolidated accounts receivable as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
The United States individually comprised at least 10% of consolidated net sales in 2024, 2023 and 2022 in the amounts of $ 10.1 billion, $ 10.5 billion and $ 10.5 billion, respectively. | text | 10.1 | monetaryItemType | text: <entity> 10.1 </entity> <entity type> monetaryItemType </entity type> <context> The United States individually comprised at least 10% of consolidated net sales in 2024, 2023 and 2022 in the amounts of $ 10.1 billion, $ 10.5 billion and $ 10.5 billion, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
The United States individually comprised at least 10% of consolidated net sales in 2024, 2023 and 2022 in the amounts of $ 10.1 billion, $ 10.5 billion and $ 10.5 billion, respectively. | text | 10.5 | monetaryItemType | text: <entity> 10.5 </entity> <entity type> monetaryItemType </entity type> <context> The United States individually comprised at least 10% of consolidated net sales in 2024, 2023 and 2022 in the amounts of $ 10.1 billion, $ 10.5 billion and $ 10.5 billion, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Brazil individually comprised at least 10% of consolidated net sales in 2024 in the amount of $ 2.5 billion. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> Brazil individually comprised at least 10% of consolidated net sales in 2024 in the amount of $ 2.5 billion. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Assets of $ 3.3 billion and $ 3.4 billion associated with our European major domestic appliance business were classified as assets held for sale and recorded at fair value less costs to sell as of December 31, 2023 and December 31, 2022, respectively. | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> Assets of $ 3.3 billion and $ 3.4 billion associated with our European major domestic appliance business were classified as assets held for sale and recorded at fair value less costs to sell as of December 31, 2023 and December 31, 2022, respectively. </context> | us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation |
Assets of $ 3.3 billion and $ 3.4 billion associated with our European major domestic appliance business were classified as assets held for sale and recorded at fair value less costs to sell as of December 31, 2023 and December 31, 2022, respectively. | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> Assets of $ 3.3 billion and $ 3.4 billion associated with our European major domestic appliance business were classified as assets held for sale and recorded at fair value less costs to sell as of December 31, 2023 and December 31, 2022, respectively. </context> | us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation |
On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. | text | 75 | percentItemType | text: <entity> 75 </entity> <entity type> percentItemType </entity type> <context> On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. </context> | us-gaap:GainLossOnSaleOfBusiness |
On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. </context> | us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown |
On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. | text | 393 | monetaryItemType | text: <entity> 393 </entity> <entity type> monetaryItemType </entity type> <context> On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses |
On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. | text | No | monetaryItemType | text: <entity> No </entity> <entity type> monetaryItemType </entity type> <context> On April 1, 2024, the parties closed the aforementioned contribution transaction and MENA sale. Upon closing in the second quarter of 2024, the transaction resulted in the deconsolidation of the European major appliances and MENA businesses. Whirlpool owns approximately 25 % and Arcelik owns approximately 75 % of the European appliance company ("Beko Europe"). In connection with the transactions, we recorded a loss on disposal of $ 1.5 billion in the fourth quarter of 2022. The loss included a write-down of the net assets of $ 1.2 billion of the disposal group to a fair value of $ 139 million and also includes $ 393 million of cumulative currency translation adjustments, $ 98 million of other comprehensive loss on pension and $ 18 million of other transaction related costs. No goodwill was included in the disposal group. </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1 |
We recorded adjustments of $ 298 million and $ 106 million for the twelve months ended December 31, 2024 and December 31, 2023, respectively, resulting in a total loss of $ 1.9 billion for the transaction. These adjustments are recorded in the loss on sale and disposal of businesses and reflect ongoing reassessment of the fair value less costs to sell of the disposal group, transaction costs and provision for tax related indemnities recorded at closing of the transaction. | text | 298 | monetaryItemType | text: <entity> 298 </entity> <entity type> monetaryItemType </entity type> <context> We recorded adjustments of $ 298 million and $ 106 million for the twelve months ended December 31, 2024 and December 31, 2023, respectively, resulting in a total loss of $ 1.9 billion for the transaction. These adjustments are recorded in the loss on sale and disposal of businesses and reflect ongoing reassessment of the fair value less costs to sell of the disposal group, transaction costs and provision for tax related indemnities recorded at closing of the transaction. </context> | us-gaap:GainLossOnSaleOfBusiness |
We recorded adjustments of $ 298 million and $ 106 million for the twelve months ended December 31, 2024 and December 31, 2023, respectively, resulting in a total loss of $ 1.9 billion for the transaction. These adjustments are recorded in the loss on sale and disposal of businesses and reflect ongoing reassessment of the fair value less costs to sell of the disposal group, transaction costs and provision for tax related indemnities recorded at closing of the transaction. | text | 106 | monetaryItemType | text: <entity> 106 </entity> <entity type> monetaryItemType </entity type> <context> We recorded adjustments of $ 298 million and $ 106 million for the twelve months ended December 31, 2024 and December 31, 2023, respectively, resulting in a total loss of $ 1.9 billion for the transaction. These adjustments are recorded in the loss on sale and disposal of businesses and reflect ongoing reassessment of the fair value less costs to sell of the disposal group, transaction costs and provision for tax related indemnities recorded at closing of the transaction. </context> | us-gaap:GainLossOnSaleOfBusiness |
We recorded adjustments of $ 298 million and $ 106 million for the twelve months ended December 31, 2024 and December 31, 2023, respectively, resulting in a total loss of $ 1.9 billion for the transaction. These adjustments are recorded in the loss on sale and disposal of businesses and reflect ongoing reassessment of the fair value less costs to sell of the disposal group, transaction costs and provision for tax related indemnities recorded at closing of the transaction. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> We recorded adjustments of $ 298 million and $ 106 million for the twelve months ended December 31, 2024 and December 31, 2023, respectively, resulting in a total loss of $ 1.9 billion for the transaction. These adjustments are recorded in the loss on sale and disposal of businesses and reflect ongoing reassessment of the fair value less costs to sell of the disposal group, transaction costs and provision for tax related indemnities recorded at closing of the transaction. </context> | us-gaap:GainLossOnSaleOfBusiness |
On January 16, 2024, the Company entered into a share purchase agreement with a third-party buyer to sell the Company's Brastemp-branded water filtration subscription business in the Latin America region and the transaction closed on July 1, 2024. The Company received proceeds of approximately 294 million Brazilian reais (approximately $ 52 million at the date of transaction) and recorded a gain of approximately $ 34 million during the third quarter of 2024. The disposal group met the criteria of held for sale at December 31, 2023. The carrying amounts of the disposal group's assets and liabilities as of December 31, 2024 and December 31, 2023, respectively, were immaterial. The disposal group's earnings (loss) available to Whirlpool before income taxes for the twelve months ended December 31, 2024, and December 31, 2023, respectively, were also immaterial. | text | 294 | monetaryItemType | text: <entity> 294 </entity> <entity type> monetaryItemType </entity type> <context> On January 16, 2024, the Company entered into a share purchase agreement with a third-party buyer to sell the Company's Brastemp-branded water filtration subscription business in the Latin America region and the transaction closed on July 1, 2024. The Company received proceeds of approximately 294 million Brazilian reais (approximately $ 52 million at the date of transaction) and recorded a gain of approximately $ 34 million during the third quarter of 2024. The disposal group met the criteria of held for sale at December 31, 2023. The carrying amounts of the disposal group's assets and liabilities as of December 31, 2024 and December 31, 2023, respectively, were immaterial. The disposal group's earnings (loss) available to Whirlpool before income taxes for the twelve months ended December 31, 2024, and December 31, 2023, respectively, were also immaterial. </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration |
On January 16, 2024, the Company entered into a share purchase agreement with a third-party buyer to sell the Company's Brastemp-branded water filtration subscription business in the Latin America region and the transaction closed on July 1, 2024. The Company received proceeds of approximately 294 million Brazilian reais (approximately $ 52 million at the date of transaction) and recorded a gain of approximately $ 34 million during the third quarter of 2024. The disposal group met the criteria of held for sale at December 31, 2023. The carrying amounts of the disposal group's assets and liabilities as of December 31, 2024 and December 31, 2023, respectively, were immaterial. The disposal group's earnings (loss) available to Whirlpool before income taxes for the twelve months ended December 31, 2024, and December 31, 2023, respectively, were also immaterial. | text | 52 | monetaryItemType | text: <entity> 52 </entity> <entity type> monetaryItemType </entity type> <context> On January 16, 2024, the Company entered into a share purchase agreement with a third-party buyer to sell the Company's Brastemp-branded water filtration subscription business in the Latin America region and the transaction closed on July 1, 2024. The Company received proceeds of approximately 294 million Brazilian reais (approximately $ 52 million at the date of transaction) and recorded a gain of approximately $ 34 million during the third quarter of 2024. The disposal group met the criteria of held for sale at December 31, 2023. The carrying amounts of the disposal group's assets and liabilities as of December 31, 2024 and December 31, 2023, respectively, were immaterial. The disposal group's earnings (loss) available to Whirlpool before income taxes for the twelve months ended December 31, 2024, and December 31, 2023, respectively, were also immaterial. </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration |
On January 16, 2024, the Company entered into a share purchase agreement with a third-party buyer to sell the Company's Brastemp-branded water filtration subscription business in the Latin America region and the transaction closed on July 1, 2024. The Company received proceeds of approximately 294 million Brazilian reais (approximately $ 52 million at the date of transaction) and recorded a gain of approximately $ 34 million during the third quarter of 2024. The disposal group met the criteria of held for sale at December 31, 2023. The carrying amounts of the disposal group's assets and liabilities as of December 31, 2024 and December 31, 2023, respectively, were immaterial. The disposal group's earnings (loss) available to Whirlpool before income taxes for the twelve months ended December 31, 2024, and December 31, 2023, respectively, were also immaterial. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> On January 16, 2024, the Company entered into a share purchase agreement with a third-party buyer to sell the Company's Brastemp-branded water filtration subscription business in the Latin America region and the transaction closed on July 1, 2024. The Company received proceeds of approximately 294 million Brazilian reais (approximately $ 52 million at the date of transaction) and recorded a gain of approximately $ 34 million during the third quarter of 2024. The disposal group met the criteria of held for sale at December 31, 2023. The carrying amounts of the disposal group's assets and liabilities as of December 31, 2024 and December 31, 2023, respectively, were immaterial. The disposal group's earnings (loss) available to Whirlpool before income taxes for the twelve months ended December 31, 2024, and December 31, 2023, respectively, were also immaterial. </context> | us-gaap:GainLossOnSaleOfBusiness |
On February 20, 2024, the Company's wholly-owned subsidiary, Whirlpool Mauritius Limited ("Seller"), executed the sale of 30.4 million equity shares of Whirlpool India via an on-market trade. The sale, which was accounted for as an equity transaction, reduced Seller's ownership in Whirlpool India from 75 % to 51 %, and generated proceeds of $ 462 million on settlement. | text | 75 | percentItemType | text: <entity> 75 </entity> <entity type> percentItemType </entity type> <context> On February 20, 2024, the Company's wholly-owned subsidiary, Whirlpool Mauritius Limited ("Seller"), executed the sale of 30.4 million equity shares of Whirlpool India via an on-market trade. The sale, which was accounted for as an equity transaction, reduced Seller's ownership in Whirlpool India from 75 % to 51 %, and generated proceeds of $ 462 million on settlement. </context> | us-gaap:MinorityInterestOwnershipPercentageByParent |
On February 20, 2024, the Company's wholly-owned subsidiary, Whirlpool Mauritius Limited ("Seller"), executed the sale of 30.4 million equity shares of Whirlpool India via an on-market trade. The sale, which was accounted for as an equity transaction, reduced Seller's ownership in Whirlpool India from 75 % to 51 %, and generated proceeds of $ 462 million on settlement. | text | 51 | percentItemType | text: <entity> 51 </entity> <entity type> percentItemType </entity type> <context> On February 20, 2024, the Company's wholly-owned subsidiary, Whirlpool Mauritius Limited ("Seller"), executed the sale of 30.4 million equity shares of Whirlpool India via an on-market trade. The sale, which was accounted for as an equity transaction, reduced Seller's ownership in Whirlpool India from 75 % to 51 %, and generated proceeds of $ 462 million on settlement. </context> | us-gaap:MinorityInterestOwnershipPercentageByParent |
On February 20, 2024, the Company's wholly-owned subsidiary, Whirlpool Mauritius Limited ("Seller"), executed the sale of 30.4 million equity shares of Whirlpool India via an on-market trade. The sale, which was accounted for as an equity transaction, reduced Seller's ownership in Whirlpool India from 75 % to 51 %, and generated proceeds of $ 462 million on settlement. | text | 462 | monetaryItemType | text: <entity> 462 </entity> <entity type> monetaryItemType </entity type> <context> On February 20, 2024, the Company's wholly-owned subsidiary, Whirlpool Mauritius Limited ("Seller"), executed the sale of 30.4 million equity shares of Whirlpool India via an on-market trade. The sale, which was accounted for as an equity transaction, reduced Seller's ownership in Whirlpool India from 75 % to 51 %, and generated proceeds of $ 462 million on settlement. </context> | us-gaap:ProceedsFromMinorityShareholders |
On August 7, 2022, the Company entered into an Asset and Stock Purchase Agreement (the “Purchase Agreement”) with Emerson Electric Co. (“Emerson”) to purchase Emerson’s InSinkErator business, a manufacturer of food waste disposers and instant hot water dispensers for home and commercial use, for a purchase price of $ 3 billion in cash, subject to customary adjustments. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> On August 7, 2022, the Company entered into an Asset and Stock Purchase Agreement (the “Purchase Agreement”) with Emerson Electric Co. (“Emerson”) to purchase Emerson’s InSinkErator business, a manufacturer of food waste disposers and instant hot water dispensers for home and commercial use, for a purchase price of $ 3 billion in cash, subject to customary adjustments. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
On October 31, 2022, we completed the acquisition of the InSinkErator business pursuant to the terms of the Purchase Agreement. We used the net proceeds from a $ 2.5 billion borrowing under our delayed draw term loan facility and $ 500 million of cash on hand to fund the acquisition. See Note 6 to the Consolidated Financial Statements for additional information about the term loan facility. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> On October 31, 2022, we completed the acquisition of the InSinkErator business pursuant to the terms of the Purchase Agreement. We used the net proceeds from a $ 2.5 billion borrowing under our delayed draw term loan facility and $ 500 million of cash on hand to fund the acquisition. See Note 6 to the Consolidated Financial Statements for additional information about the term loan facility. </context> | us-gaap:ProceedsFromIssuanceOfLongTermDebt |
Goodwill of $ 1.1 billion which is not deductible for tax purposes, arose from this transaction and is allocated to the MDA North America reportable segment, and consists of expected future economic benefits arising from expected future product sales, value creation opportunities, operating efficiencies and other synergies that might result from the acquisition. The allocation has been made on the basis that the anticipated synergies identified will primarily benefit this reportable segment. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> Goodwill of $ 1.1 billion which is not deductible for tax purposes, arose from this transaction and is allocated to the MDA North America reportable segment, and consists of expected future economic benefits arising from expected future product sales, value creation opportunities, operating efficiencies and other synergies that might result from the acquisition. The allocation has been made on the basis that the anticipated synergies identified will primarily benefit this reportable segment. </context> | us-gaap:Goodwill |
During the year ended December 31, 2022, we incurred transaction and other costs in connection with the acquisition of approximately $ 44 million which are included in Selling, general and administrative expense in our Consolidated Statements of Income (Loss). | text | 44 | monetaryItemType | text: <entity> 44 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, we incurred transaction and other costs in connection with the acquisition of approximately $ 44 million which are included in Selling, general and administrative expense in our Consolidated Statements of Income (Loss). </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
On August 31, 2022, we completed the sale to Arcelik. The consideration includes contingent consideration based on future business and other conditions of the Russian operations. We will recognize the benefit of the contingent consideration when received due to the uncertainty in the Russian marketplace. Additionally, the contingent consideration is subject to a cap based on the agreed net asset value of the Russia business of € 261 million at closing (approximately $ 262 million at August 31, 2022). | text | 261 | monetaryItemType | text: <entity> 261 </entity> <entity type> monetaryItemType </entity type> <context> On August 31, 2022, we completed the sale to Arcelik. The consideration includes contingent consideration based on future business and other conditions of the Russian operations. We will recognize the benefit of the contingent consideration when received due to the uncertainty in the Russian marketplace. Additionally, the contingent consideration is subject to a cap based on the agreed net asset value of the Russia business of € 261 million at closing (approximately $ 262 million at August 31, 2022). </context> | us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure |
On August 31, 2022, we completed the sale to Arcelik. The consideration includes contingent consideration based on future business and other conditions of the Russian operations. We will recognize the benefit of the contingent consideration when received due to the uncertainty in the Russian marketplace. Additionally, the contingent consideration is subject to a cap based on the agreed net asset value of the Russia business of € 261 million at closing (approximately $ 262 million at August 31, 2022). | text | 262 | monetaryItemType | text: <entity> 262 </entity> <entity type> monetaryItemType </entity type> <context> On August 31, 2022, we completed the sale to Arcelik. The consideration includes contingent consideration based on future business and other conditions of the Russian operations. We will recognize the benefit of the contingent consideration when received due to the uncertainty in the Russian marketplace. Additionally, the contingent consideration is subject to a cap based on the agreed net asset value of the Russia business of € 261 million at closing (approximately $ 262 million at August 31, 2022). </context> | us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure |
In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. | text | 346 | monetaryItemType | text: <entity> 346 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. </context> | us-gaap:GainLossOnSaleOfBusiness |
In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. | text | 333 | monetaryItemType | text: <entity> 333 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. </context> | us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown |
In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. | text | 13 | monetaryItemType | text: <entity> 13 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses |
In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. | text | 348 | monetaryItemType | text: <entity> 348 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the sale, we recorded a loss on disposal of $ 346 million in the second quarter of 2022. The loss included a charge of $ 333 million for the write-down of the net assets of the disposal group to fair value and $ 13 million of cumulative currency translation adjustments. On the closing date of August 31, 2022, we recorded an immaterial adjustment to the final loss amount, resulting in a total loss of $ 348 million for the nine months ended September 30, 2022. </context> | us-gaap:GainLossOnSaleOfBusiness |
The number of shares of common stock outstanding, par value $ 0.01 per share, of the registrant as of February 21, 2025 was 1,193,688,749 . | text | 0.01 | perShareItemType | text: <entity> 0.01 </entity> <entity type> perShareItemType </entity type> <context> The number of shares of common stock outstanding, par value $ 0.01 per share, of the registrant as of February 21, 2025 was 1,193,688,749 . </context> | us-gaap:CommonStockParOrStatedValuePerShare |
The Company operates in more than 165 countries and territories with approximately 32,000 employees. The Company has 26 manufacturing and packaging sites worldwide, more than 1,400 approved molecules, and industry leading commercial, R&D, regulatory, manufacturing, legal and medical expertise. Viatris’ portfolio consists of generics (including complex products), globally recognized iconic brands, and an expanding portfolio of innovative medicines. We conduct our business through four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India. | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> The Company operates in more than 165 countries and territories with approximately 32,000 employees. The Company has 26 manufacturing and packaging sites worldwide, more than 1,400 approved molecules, and industry leading commercial, R&D, regulatory, manufacturing, legal and medical expertise. Viatris’ portfolio consists of generics (including complex products), globally recognized iconic brands, and an expanding portfolio of innovative medicines. We conduct our business through four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India. </context> | us-gaap:NumberOfReportableSegments |
The Company paid quarterly cash dividends of $ 0.12 per share on the Company’s issued and outstanding common stock on March 18, 2024, June 14, 2024, September 13, 2024 and December 13, 2024. On February 24, 2025, the Company’s Board of Directors declared a quarterly cash dividend of $ 0.12 per share on the Company’s issued and outstanding common stock, which will be payable on March 18, 2025 to shareholders of record as of the close of business on March 10, 2025. The declaration and payment of future dividends to holders of the Company’s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company’s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant. The Company also paid quarterly cash dividends of $ 0.12 per share on the Company’s issued and outstanding common stock in each of the four quarters of 2023 and 2022. | text | 0.12 | perShareItemType | text: <entity> 0.12 </entity> <entity type> perShareItemType </entity type> <context> The Company paid quarterly cash dividends of $ 0.12 per share on the Company’s issued and outstanding common stock on March 18, 2024, June 14, 2024, September 13, 2024 and December 13, 2024. On February 24, 2025, the Company’s Board of Directors declared a quarterly cash dividend of $ 0.12 per share on the Company’s issued and outstanding common stock, which will be payable on March 18, 2025 to shareholders of record as of the close of business on March 10, 2025. The declaration and payment of future dividends to holders of the Company’s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company’s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant. The Company also paid quarterly cash dividends of $ 0.12 per share on the Company’s issued and outstanding common stock in each of the four quarters of 2023 and 2022. </context> | us-gaap:CommonStockDividendsPerShareDeclared |
On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. | text | 19.2 | sharesItemType | text: <entity> 19.2 </entity> <entity type> sharesItemType </entity type> <context> On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. | text | 250 | monetaryItemType | text: <entity> 250 </entity> <entity type> monetaryItemType </entity type> <context> On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. | text | 21.2 | sharesItemType | text: <entity> 21.2 </entity> <entity type> sharesItemType </entity type> <context> On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $ 1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $ 1.0 billion increase to the Company’s previously announced $ 1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $ 2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. During the years ended December 31, 2024 and 2023, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $ 250 million, and approximately 21.2 million shares of common stock at a cost of approximately $ 250 million, respectively, under the program. The Company did not repurchase any shares of common stock under the share repurchase program in 2022. The share repurchase program does not obligate the Company to acquire any particular amount of common stock. The Company had repurchased a total of $ 500 million in shares through December 31, 2024 under the program. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
Total allowances for doubtful accounts were $ 107.6 million and $ 118.8 million at December 31, 2024 and 2023, respectively. The reduction in accounts receivable includes the impact of divestitures. Refer to Note 5 | text | 107.6 | monetaryItemType | text: <entity> 107.6 </entity> <entity type> monetaryItemType </entity type> <context> Total allowances for doubtful accounts were $ 107.6 million and $ 118.8 million at December 31, 2024 and 2023, respectively. The reduction in accounts receivable includes the impact of divestitures. Refer to Note 5 </context> | us-gaap:ValuationAllowancesAndReservesBalance |
Total allowances for doubtful accounts were $ 107.6 million and $ 118.8 million at December 31, 2024 and 2023, respectively. The reduction in accounts receivable includes the impact of divestitures. Refer to Note 5 | text | 118.8 | monetaryItemType | text: <entity> 118.8 </entity> <entity type> monetaryItemType </entity type> <context> Total allowances for doubtful accounts were $ 107.6 million and $ 118.8 million at December 31, 2024 and 2023, respectively. The reduction in accounts receivable includes the impact of divestitures. Refer to Note 5 </context> | us-gaap:ValuationAllowancesAndReservesBalance |
for additional information. Viatris performs ongoing credit evaluations of its customers and generally does not require collateral. Approximately 29 % and 28 % of the accounts receivable balances represent amounts due from three customers at December 31, 2024 and 2023, respectively. | text | 29 | percentItemType | text: <entity> 29 </entity> <entity type> percentItemType </entity type> <context> for additional information. Viatris performs ongoing credit evaluations of its customers and generally does not require collateral. Approximately 29 % and 28 % of the accounts receivable balances represent amounts due from three customers at December 31, 2024 and 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
for additional information. Viatris performs ongoing credit evaluations of its customers and generally does not require collateral. Approximately 29 % and 28 % of the accounts receivable balances represent amounts due from three customers at December 31, 2024 and 2023, respectively. | text | 28 | percentItemType | text: <entity> 28 </entity> <entity type> percentItemType </entity type> <context> for additional information. Viatris performs ongoing credit evaluations of its customers and generally does not require collateral. Approximately 29 % and 28 % of the accounts receivable balances represent amounts due from three customers at December 31, 2024 and 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of | text | 68.5 | monetaryItemType | text: <entity> 68.5 </entity> <entity type> monetaryItemType </entity type> <context> We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of </context> | us-gaap:ProceedsFromSaleAndCollectionOfReceivables |
We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of | text | 30.8 | monetaryItemType | text: <entity> 30.8 </entity> <entity type> monetaryItemType </entity type> <context> We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of </context> | us-gaap:ProceedsFromSaleAndCollectionOfReceivables |
We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of | text | 29.9 | monetaryItemType | text: <entity> 29.9 </entity> <entity type> monetaryItemType </entity type> <context> We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of </context> | us-gaap:TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfAssetsObtainedAsProceeds |
We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of | text | 415.7 | monetaryItemType | text: <entity> 415.7 </entity> <entity type> monetaryItemType </entity type> <context> We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $ 68.5 million and $ 30.8 million of accounts receivable as of December 31, 2024 and 2023, respectively, under these factoring arrangements. Additionally, in 2023, we entered into a similar arrangement for certain European countries. As of December 31, 2024 and 2023, we assigned and derecognized approximately $ 29.9 million and $ 415.7 million, respectively, of </context> | us-gaap:TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfAssetsObtainedAsProceeds |
On March 15, 2024, the Company acquired exclusive global development and commercialization rights to two Phase 3 assets from Idorsia, as well as the potential to add additional innovative assets in the future. Under the terms of the original agreements, the development programs and certain personnel for selatogrel and cenerimod were transferred to Viatris from Idorsia in exchange for an upfront payment to Idorsia of $ 350 million, potential contingent milestone payments (including $ 300 million payable upon the achievement of certain development and regulatory milestones, and $ 2.1 billion payable upon the achievement of certain tiered sales milestones), as well as potential contingent tiered sales royalties. Viatris and Idorsia are both contractually obligated to contribute to the development costs for both programs. Viatris has worldwide commercialization rights for both selatogrel and cenerimod (excluding, for cenerimod only, Japan, South Korea and certain countries in the Asia-Pacific region). A joint development committee was formed to oversee the development of the ongoing Phase 3 programs through regulatory approval. The agreements also provide Viatris a right of first refusal and a right of first negotiation for certain other assets in Idorsia’s pipeline. The transaction expanded our portfolio of innovative assets by adding two Phase 3 assets and combines our financial strength and worldwide operational infrastructure with Idorsia’s proven, highly-productive drug development team and innovation engine. | text | 350 | monetaryItemType | text: <entity> 350 </entity> <entity type> monetaryItemType </entity type> <context> On March 15, 2024, the Company acquired exclusive global development and commercialization rights to two Phase 3 assets from Idorsia, as well as the potential to add additional innovative assets in the future. Under the terms of the original agreements, the development programs and certain personnel for selatogrel and cenerimod were transferred to Viatris from Idorsia in exchange for an upfront payment to Idorsia of $ 350 million, potential contingent milestone payments (including $ 300 million payable upon the achievement of certain development and regulatory milestones, and $ 2.1 billion payable upon the achievement of certain tiered sales milestones), as well as potential contingent tiered sales royalties. Viatris and Idorsia are both contractually obligated to contribute to the development costs for both programs. Viatris has worldwide commercialization rights for both selatogrel and cenerimod (excluding, for cenerimod only, Japan, South Korea and certain countries in the Asia-Pacific region). A joint development committee was formed to oversee the development of the ongoing Phase 3 programs through regulatory approval. The agreements also provide Viatris a right of first refusal and a right of first negotiation for certain other assets in Idorsia’s pipeline. The transaction expanded our portfolio of innovative assets by adding two Phase 3 assets and combines our financial strength and worldwide operational infrastructure with Idorsia’s proven, highly-productive drug development team and innovation engine. </context> | us-gaap:BusinessCombinationPriceOfAcquisitionExpected |
In accordance with U.S. GAAP, the transaction has been accounted for as a business combination under the acquisition method of accounting. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. During the year ended December 31, 2024, the Company incurred acquisition-related costs of approximately $ 3.9 million, which were recorded primarily in | text | 3.9 | monetaryItemType | text: <entity> 3.9 </entity> <entity type> monetaryItemType </entity type> <context> In accordance with U.S. GAAP, the transaction has been accounted for as a business combination under the acquisition method of accounting. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction were recorded at their respective estimated fair values at the acquisition date. During the year ended December 31, 2024, the Company incurred acquisition-related costs of approximately $ 3.9 million, which were recorded primarily in </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
The U.S. GAAP purchase price allocated to the transaction was $ 695 million, which consisted of $ 350 million of cash consideration paid and estimated contingent consideration at the date of acquisition valued at approximately $ 345 million. The fair value of the contingent consideration was valued using a Monte Carlo simulation model using Level 3 inputs. The fair value is sensitive to changes in the forecasts of operating metrics, probability of success, and discount rates. Refer to Note 9, | text | 695 | monetaryItemType | text: <entity> 695 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. GAAP purchase price allocated to the transaction was $ 695 million, which consisted of $ 350 million of cash consideration paid and estimated contingent consideration at the date of acquisition valued at approximately $ 345 million. The fair value of the contingent consideration was valued using a Monte Carlo simulation model using Level 3 inputs. The fair value is sensitive to changes in the forecasts of operating metrics, probability of success, and discount rates. Refer to Note 9, </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The U.S. GAAP purchase price allocated to the transaction was $ 695 million, which consisted of $ 350 million of cash consideration paid and estimated contingent consideration at the date of acquisition valued at approximately $ 345 million. The fair value of the contingent consideration was valued using a Monte Carlo simulation model using Level 3 inputs. The fair value is sensitive to changes in the forecasts of operating metrics, probability of success, and discount rates. Refer to Note 9, | text | 350 | monetaryItemType | text: <entity> 350 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. GAAP purchase price allocated to the transaction was $ 695 million, which consisted of $ 350 million of cash consideration paid and estimated contingent consideration at the date of acquisition valued at approximately $ 345 million. The fair value of the contingent consideration was valued using a Monte Carlo simulation model using Level 3 inputs. The fair value is sensitive to changes in the forecasts of operating metrics, probability of success, and discount rates. Refer to Note 9, </context> | us-gaap:BusinessCombinationPriceOfAcquisitionExpected |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.